Copyright
©The Author(s) 2015.
World J Hepatol. Apr 8, 2015; 7(4): 717-720
Published online Apr 8, 2015. doi: 10.4254/wjh.v7.i4.717
Published online Apr 8, 2015. doi: 10.4254/wjh.v7.i4.717
Years postimplantation | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | > 10 | Total |
Patient at risk (n) | 4000 | 2940 | 2665 | 2478 | 2261 | 2018 | 1732 | 1511 | 1238 | 958 | 735 | |
Infection (bacterial, viral, fungal) | 372 | 38 | 13 | 16 | 4 | 6 | 8 | 1 | 3 | 1 | 2 | 464 (28.4) |
Malignancy (recurrent/de novo) | 42 | 45 | 28 | 18 | 11 | 19 | 12 | 6 | 3 | 6 | 190 (11.6) | |
Cardiovascular | 42 | 14 | 6 | 1 | 13 | 17 | 13 | 9 | 6 | 5 | 9 | 135 (8.3) |
Respiratory | 37 | 20 | 14 | 7 | 8 | 3 | 3 | 4 | 5 | 4 | 9 | 114 (7.0) |
Intraoperative | 99 | 4 | 1 | 2 | 4 | 2 | 1 | 113 (6.9) | ||||
Multisystem organ failure | 45 | 16 | 9 | 5 | 6 | 9 | 5 | 7 | 3 | 1 | 3 | 109 (6.7) |
Liver failure (recurrent) | 21 | 15 | 15 | 7 | 10 | 6 | 3 | 2 | 1 | 2 | 82 (5.9) | |
Gastrointestinal | 31 | 6 | 2 | 4 | 5 | 1 | 1 | 1 | 1 | 52 (3.2) | ||
Central nervous system | 20 | 2 | 2 | 4 | 1 | 5 | 3 | 1 | 4 | 42 (2.6) | ||
PTLD | 8 | 5 | 6 | 2 | 3 | 1 | 1 | 1 | 2 | 29 (1.8) | ||
Renal failure | 8 | 5 | 1 | 3 | 1 | 18 (1.1) | ||||||
Rejection (acute/chronic) | 4 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 4 | 18 (1.1) | ||
Primary nonfunction | 13 | 1 | 14 (1.1) | |||||||||
Miscellaneous | 27 | 15 | 7 | 12 | 10 | 12 | 8 | 10 | 7 | 5 | 5 | 118 (6.1) |
Unknown | 55 | 20 | 18 | 5 | 5 | 7 | 4 | 5 | 4 | 1 | 11 | 135 (8.3) |
Total | 816 (20.4) | 197 (6.7) | 122 (4.5) | 96 (3.8) | 85 (3.7) | 93 (4.6) | 62 (3.5) | 50 (3.3) | 36 (2.9) | 19 (1.9) | 57 (7.7) | 1633 |
- Citation: Unlu O, Roach EC, Okoh A, Olayan M, Yilmaz B, Uzunaslan D, Shatnawei A. Skin cancer in immunosuppressed transplant patients: Vigilance matters. World J Hepatol 2015; 7(4): 717-720
- URL: https://www.wjgnet.com/1948-5182/full/v7/i4/717.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i4.717